Bio-Techne Corporation (NASDAQ:TECH) Q2 2025 Earnings Conference Call
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Second Quarter of Fiscal Year 2025.
Company Participants:
David Clair – Vice President-Investor Relations
Kim Kelderman – President and Chief Executive Officer
Jim Hippel – Executive Vice President and Chief Financial Officer
Conference Call Participants:
Puneet Souda – Leerink Partners
Dan Leonard – UBS
Matt Larew – William Blair
Catherine Schulte – Baird
Dan Arias – Stifel
Conor McNamara – RBC
Patrick Donnelly – Citi
Sung Ji Nam – Scotiabank
At this time, all participants have been placed in a listen-only mode and the call will be open for questions following management’s prepared remarks.
Today we are here to discuss the second quarter earnings of Bio-Techne Corporation for the fiscal year 2025. This is an exciting time for the company as we continue to innovate and grow in the biotech industry.
We have seen strong growth in our key markets and are optimistic about the future. Our dedicated team and innovative products have contributed to our success, and we look forward to sharing more details with you today.
Now I would like to turn the call over to our President and Chief Executive Officer, Kim Kelderman, to provide an overview of our financial performance and strategic initiatives.
Impact on You:
As a shareholder or potential investor in Bio-Techne Corporation, the positive earnings report for the second quarter of fiscal year 2025 is likely to increase your confidence in the company’s growth and profitability. This can lead to higher stock prices and potentially greater returns on your investment.
Impact on the World:
The success of Bio-Techne Corporation in the biotech industry can have broader implications for the world. The company’s innovative products and research could lead to advancements in healthcare, pharmaceuticals, and biotechnology, ultimately benefiting society as a whole by improving treatments and finding solutions to complex diseases.
Conclusion:
In conclusion, the second quarter earnings conference call for Bio-Techne Corporation has provided valuable insights into the company’s performance and future prospects. With a strong team and innovative products, Bio-Techne is poised for continued growth and success in the biotech industry.
